PANAGORA ASSET MANAGEMENT INC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 883677 Boston, MA

Position in FULC

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$349,606

-$1,518,537 QoQ

Shares Held

95,521

-60.8% QoQ

Ownership

0.125%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#63

of 154 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. FULC ranks #69 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	175,291	$109,300,950
2	INCY	Incyte Corp	881,889	$99,970,937
3	XENE	Xenon Pharmaceuticals Inc.	664,031	$40,080,911
4	MIRM	Mirum Pharmaceuticals, Inc.	337,461	$39,506,559
5	TVTX	Travere Therapeutics, Inc.	490,724	$27,878,030
6	JAZZ	Jazz Pharmaceuticals plc	104,935	$25,286,186
7	RLAY	Relay Therapeutics, Inc.	1,291,182	$24,158,015
8	CLDX	Celldex Therapeutics, Inc.	572,538	$21,304,138

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$349,606	95,521	-60.8%	Shares	Sole	2026-08-06
2026-03-31	$1,868,143	243,565	+148.8%	Shares	Sole	2026-05-14
2024-09-30	$349,470	97,891	+339.0%	Shares	Sole	2024-11-13
2023-03-31	$63,552	22,299	-4.0%	Shares	Sole	2023-05-12
2022-12-31	$169,158	23,236	-20.0%	Shares	Sole	2023-02-13
2022-09-30	$235,103	29,061	+1.4%	Shares	Sole	2022-11-14
2022-06-30	$140,365	28,646	0.0%	Shares	Sole	2022-08-15
2022-03-31	$677,477	28,646	+0.4%	Shares	Sole	2022-05-12
2021-12-31	$504,872	28,540	+0.5%	Shares	Sole	2022-02-10
2021-09-30	$801,361	28,407	+3330.8%	Shares	Sole	2021-11-10
2021-06-30	$8,677	828	+111.2%	Shares	Sole	2021-08-11
2021-03-31	$4,617	392	0.0%	Shares	Sole	2021-05-12
2020-12-31	$4,590	392	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.